Recombinant Neurospora crassa COP9 signalosome complex subunit 4 (csn-4)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. Please specify your desired tag type for preferential development.
Synonyms
csn-4; NCU07361; COP9 signalosome complex subunit 4; Signalosome subunit 4
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-440
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)
Target Names
csn-4
Target Protein Sequence
MVSSEVRDLL AQVPNWSQAD RPAAFRTIIT TITSSPDPSH FAADLKAVTD AIFLESLGVV ATRALVIDLI DALKSLASGG PSADSINSTT SSIWLDVGKA IQQHIQSNPT LATSLVDQTA TIYEELLAAA HESQNSFTDA AKTLAAIPLD SSQRRVTDKY KADLWIRIIR NYLEDDDATS AETYLNKLKN IIHNVADDNP VLNLHFKLSA ARIQDSNRQF LAASQSYYEI SLSPAIAEEE RLHTLSMAIK CAVLAPAGPP RSRVLARLYK DERSASLEEF GILEKMFLDR LLARAEVEKF AQGLAPHQLA TTSDGSTVLA KAMVEHNLLA VSRLYRNIGF DALGSWLGLD SGNKAEEITA RMIEQGRLAG SIDQIDRIIY FESGLEASGE KGSGRAEVPV GKEMRRQDGM VQALAEDLER ITDDLLVEFP QLVPAGVPGN
Uniprot No.

Target Background

Function
A component of the COP9 signalosome (CSN) complex, it regulates the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of cullin subunits in SCF-type E3 ubiquitin-protein ligase complexes. The CSN complex plays a crucial role in circadian clock regulation via its control over SCF(FWD1) complex stability.
Database Links

KEGG: ncr:NCU07361

Protein Families
CSN4 family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is the structural composition of the Neurospora crassa COP9 signalosome complex?

The Neurospora crassa COP9 signalosome follows the conserved structure found across eukaryotes, consisting of eight core subunits (CSN1-8). The complex contains six Proteasome-COP9 signalosome-Initiation factor 3 (PCI) domain proteins and two MOV34-Pad1-N-terminal (MPN) domain proteins . CSN-4 contains a PCI domain that contributes to the horseshoe-like ring structure formed by the six PCI domain subunits. All eight subunits are connected by a bundle of C-terminal α-helices, creating a scaffold for additional interacting proteins .

How conserved is CSN-4 across different fungal species?

CSN-4 is highly conserved across fungal species, reflecting the evolutionary importance of the COP9 signalosome. Comparative studies have identified CSN homologs in various fungi including Saccharomyces cerevisiae, Schizosaccharomyces pombe, and Aspergillus nidulans . The high degree of conservation suggests that CSN-4 plays a fundamental role in cellular processes regulated by protein ubiquitination. Sequence alignment analyses typically show conservation of key structural domains, particularly the PCI domain and C-terminal helical regions that contribute to complex formation.

What are the optimal conditions for purifying recombinant CSN-4?

Purification of recombinant CSN-4 is typically achieved through a multi-step process:

  • Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin

  • Intermediate purification: Ion exchange chromatography (typically Q-Sepharose)

  • Polishing: Size exclusion chromatography

Buffer optimization is crucial, with recommended conditions including:

Purification StepBuffer CompositionpHTemperature
IMAC50 mM Tris-HCl, 300 mM NaCl, 10-250 mM imidazole, 5% glycerol, 1 mM DTT8.04°C
Ion Exchange20 mM Tris-HCl, 50-500 mM NaCl gradient, 5% glycerol, 1 mM DTT7.54°C
Size Exclusion20 mM HEPES, 150 mM NaCl, 5% glycerol, 1 mM DTT7.54°C

Addition of protease inhibitors (PMSF, leupeptin, aprotinin) is recommended throughout the purification process to prevent degradation .

How can researchers assess the proper folding and activity of purified recombinant CSN-4?

Assessment of properly folded recombinant CSN-4 involves several complementary approaches:

  • Circular dichroism (CD) spectroscopy to evaluate secondary structure content

  • Thermal shift assays to assess protein stability

  • Limited proteolysis to confirm compactly folded domains

  • Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) to verify monomeric state and molecular weight

Since CSN-4 alone does not possess enzymatic activity, functional assessment requires reconstitution experiments with other CSN subunits. In vitro reconstitution of partial or complete CSN complexes followed by deneddylation assays using neddylated cullins as substrates can verify the contribution of CSN-4 to complex formation and activity . Pull-down assays can also be used to confirm the ability of purified CSN-4 to interact with its binding partners within the CSN complex.

What techniques are most informative for studying CSN-4 structural dynamics?

Multiple complementary approaches provide insights into CSN-4 structural dynamics:

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map conformational changes and solvent accessibility

  • Cross-linking mass spectrometry (XL-MS) using multi-chemistry cross-linkers to capture interaction interfaces

  • Small-angle X-ray scattering (SAXS) for low-resolution structural information in solution

  • Cryo-electron microscopy for visualization of CSN-4 within the complete CSN complex

Recent advances in integrative structural biology combining multiple cross-linkers with mass spectrometry have proven particularly valuable for understanding CSN complex dynamics . For example, applying mass spectrometry-cleavable cross-linkers such as DHSO (disuccinimidyl dibutyric urea) can generate reliable cross-link data to map interaction interfaces between CSN-4 and other CSN subunits .

How does CSN-4 contribute to the conformational changes of the CSN complex during substrate binding?

CSN-4 plays a significant role in the conformational changes that occur during CSN interaction with neddylated CRLs. Quantitative cross-linking studies have revealed that conformational repositioning of CSN subunits is essential for CSN activation upon substrate binding . CSN-4 likely participates in a network of interactions that shift during substrate recognition, particularly through repositioning relative to CSN2, as observed in parallel reaction monitoring (PRM)-based targeted quantitation of cross-links . These conformational changes are critical for proper positioning of the catalytic CSN5 subunit to access the neddylated cullin substrate.

What is the role of CSN-4 in the assembly pathway of the complete CSN complex?

Studies in Aspergillus nidulans have demonstrated that CSN assembly likely involves formation of a stable seven-subunit pre-CSN complex (lacking CSN5/CsnE) without deneddylase activity . CSN-4 is required for proper assembly of this pre-complex. The integration of CSN5 into this pre-complex represents the final step in assembly, leading to activation of deneddylase activity. Reconstitution experiments with crude extracts of deletion strains and recombinant proteins support this assembly model . CSN-4 likely forms critical interactions that stabilize the pre-CSN complex, creating a structural framework ready for CSN5 integration and subsequent activation.

What phenotypes are associated with CSN-4 deficiency in Neurospora crassa?

CSN-4 deficiency in N. crassa results in several observable phenotypes:

  • Defects in circadian rhythmicity and light responses

  • Abnormal sexual and asexual development

  • Altered secondary metabolism profiles

  • Dysregulation of the ubiquitin-proteasome system

Based on studies in Aspergillus nidulans, deletion of any CSN subunit impairs deneddylase activity and causes identical defects in the coordination of development and secondary metabolism . In N. crassa, the nitrogen control circuit may also be affected, given the regulatory relationship between CSN activity and the nitrate utilization pathway, which includes transcription factors like NIT2 and NIT4 .

How can researchers generate and validate CSN-4 knockout strains in N. crassa?

Generation of CSN-4 knockout strains in N. crassa involves several key steps:

  • Construct design: Create a deletion cassette containing a selectable marker (typically hygromycin B resistance) flanked by ~1kb homologous sequences upstream and downstream of the csn-4 gene

  • Transformation: Use polyethylene glycol (PEG)-mediated transformation of N. crassa conidia with the deletion cassette

  • Selection: Culture transformants on media containing hygromycin B

  • Validation: Confirm deletion via PCR, Southern blotting, and western blotting

Validation MethodPrimers/Probes/AntibodiesExpected Results
PCRPrimers flanking the csn-4 locusSize difference between WT and knockout
Southern BlotProbe specific to csn-4 or selectable markerAbsence of csn-4 band, presence of marker band
Western BlotAnti-CSN-4 antibodyAbsence of CSN-4 protein in knockout strain
RT-PCRcsn-4 specific primersNo csn-4 mRNA expression

Complementation experiments reintroducing the wild-type csn-4 gene are essential to confirm that observed phenotypes are specifically due to CSN-4 deficiency rather than secondary mutations.

What approaches can be used to study the interaction network of CSN-4 in vivo?

Multiple approaches can elucidate the CSN-4 interaction network in vivo:

  • Co-immunoprecipitation (Co-IP) with tagged CSN-4 followed by mass spectrometry

  • Proximity-dependent biotin identification (BioID) using CSN-4 fused to a biotin ligase

  • Yeast two-hybrid screening with CSN-4 as bait

  • In situ chemical cross-linking followed by mass spectrometry

  • Fluorescence resonance energy transfer (FRET) between fluorescently tagged CSN-4 and potential interaction partners

An effective experimental design would include:

  • Generation of N. crassa strains expressing epitope-tagged CSN-4 (e.g., FLAG, HA, or GFP)

  • Verification of tagged protein functionality through complementation of csn-4 knockout phenotypes

  • Optimization of extraction conditions to preserve native protein interactions

  • Implementation of appropriate controls (e.g., untagged strains, non-specific antibodies)

  • Validation of key interactions through reciprocal Co-IP experiments

How can researchers effectively reconstitute the CSN complex including CSN-4 for in vitro studies?

In vitro reconstitution of the CSN complex requires a stepwise approach:

  • Individual subunit expression: Express and purify all eight CSN subunits individually, including CSN-4, using compatible affinity tags

  • Subcomplex formation: Assemble stable subcomplexes (e.g., CSN1/2/3/4 and CSN5/6/7/8) by mixing equimolar amounts of purified subunits

  • Complete complex assembly: Combine subcomplexes with adjustment of buffer conditions to favor stable interactions

  • Complex purification: Perform size exclusion chromatography to isolate the fully assembled complex

For functional studies, a reconstitution strategy based on the proposed CSN assembly pathway has proven effective . This involves:

  • Assembly of the seven-subunit pre-CSN complex (without CSN5)

  • Addition of purified CSN5 under conditions that promote its integration

  • Verification of complex formation by analytical size exclusion chromatography and native PAGE

The reconstituted complex should be tested for deneddylase activity using neddylated cullins as substrates to confirm proper assembly and functionality.

What are the most sensitive methods for measuring CSN-mediated deneddylation activity?

Several approaches offer sensitive detection of deneddylation activity:

  • Western blotting with anti-Nedd8 antibodies to detect deneddylation of cullins

  • FRET-based assays using Nedd8 conjugated to fluorescent proteins

  • Fluorescently labeled Nedd8 substrates with fluorescence polarization detection

  • Time-resolved mass spectrometry to monitor substrate conversion

For quantitative kinetic analysis, a recommended experimental setup includes:

ComponentConcentrationNotes
Reconstituted CSN complex5-50 nMIncluding CSN-4
Neddylated cullin substrate0.1-1 μMPurified from insect cells or in vitro neddylated
Buffer20 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 5% glycerolMay require optimization
Temperature25°CMonitor at multiple time points

For high-throughput screening applications, FRET-based assays offer the best combination of sensitivity and throughput, though western blotting remains the gold standard for validation studies.

How can researchers investigate the effect of CSN-4 mutations on complex assembly and function?

A systematic approach to investigate CSN-4 mutations includes:

  • Structure-based mutation design: Target conserved residues in the PCI domain, predicted interaction interfaces, or the C-terminal helical bundle

  • Site-directed mutagenesis: Generate mutations in the recombinant CSN-4 expression construct

  • Protein expression and purification: Compare wild-type and mutant proteins for solubility and stability

  • In vitro reconstitution: Assess the ability of mutant CSN-4 to incorporate into the CSN complex

  • Functional assays: Measure deneddylase activity of reconstituted complexes containing mutant CSN-4

  • In vivo complementation: Test the ability of mutant csn-4 to rescue knockout phenotypes

Critical mutations might include:

  • Conserved hydrophobic residues in the PCI domain that contribute to domain stability

  • Charged residues at predicted protein-protein interfaces

  • Residues in the C-terminal helical region that contribute to complex assembly

Techniques such as thermal shift assays can rapidly identify mutations that affect protein stability, while size exclusion chromatography can assess complex formation capabilities.

How does CSN-4 contribute to CRL substrate specificity in N. crassa?

CSN-4 likely contributes to CRL substrate specificity through its role in the structural dynamics of the CSN complex. Investigating this relationship requires:

  • Identification of CRL substrates affected by CSN-4 deficiency using quantitative proteomics

  • Comparison of ubiquitination patterns between wild-type and CSN-4 deficient strains

  • Analysis of cullin neddylation status in the presence of wild-type vs. mutant CSN-4

  • Identification of potential direct interactions between CSN-4 and specific CRL components

A comprehensive experimental approach would involve stable isotope labeling with amino acids in cell culture (SILAC) followed by immunoprecipitation of ubiquitinated proteins and mass spectrometry analysis. This would allow identification of proteins with altered ubiquitination and degradation rates in CSN-4 deficient strains compared to wild-type.

What is the relationship between CSN-4 and the newly discovered CSN9 subunit?

The relationship between CSN-4 and CSN9 presents an interesting research direction. While CSN9 has been shown to interact primarily with CSN3 and CSN1 , investigation of potential CSN4-CSN9 relationships would involve:

  • Targeted cross-linking mass spectrometry to identify direct contacts

  • Co-immunoprecipitation experiments with tagged CSN-4 and CSN9

  • Structural analysis of CSN conformational changes induced by CSN9 binding

  • Functional analysis of deneddylase activity in reconstituted complexes with various combinations of CSN-4 and CSN9

Recent studies have shown that CSN9 triggers conformational changes in the CSN complex, particularly affecting the positioning of CSN2 relative to CSN4 . These changes appear to facilitate CSN interaction with neddylated CRLs. Experiments comparing the structure and function of CSN complexes with and without CSN9 in the context of wild-type versus mutant CSN-4 would provide valuable insights into their functional relationship.

How does CSN-4 function in the context of the nitrogen control circuit in N. crassa?

Investigating the role of CSN-4 in the nitrogen control circuit requires integration of multiple approaches:

  • Chromatin immunoprecipitation (ChIP) analysis to identify changes in NIT2 and NIT4 binding to target promoters in CSN-4 deficient strains

  • Transcriptome analysis to identify genes differentially expressed in response to nitrogen source changes in wild-type versus CSN-4 deficient strains

  • Protein stability analysis of key nitrogen circuit components (e.g., NIT2, NIT4) in the presence and absence of CSN-4

  • Investigation of potential direct interactions between CSN-4/CSN complex and nitrogen-responsive transcription factors

Given that NIT2 and NIT4 cooperatively regulate genes like nit-3 in response to nitrogen availability , and that CSN regulates protein stability through the ubiquitin-proteasome system, CSN-4 may influence nitrogen metabolism by modulating the stability or activity of these transcription factors.

What are common challenges in CSN-4 expression and purification, and how can they be addressed?

Common challenges and their solutions include:

ChallengeProbable CauseSolution
Low expression yieldPoor codon optimizationUse codon-optimized sequence for E. coli or expression host
Insoluble proteinRapid overexpression, improper foldingLower induction temperature (16°C), co-express with chaperones
Protein degradationProteolytic sensitivityInclude protease inhibitors, reduce purification time
Aggregation during purificationHydrophobic patches exposureInclude mild detergents (0.05% Tween-20) or higher salt (300-500 mM NaCl)
Poor binding to affinity resinTag inaccessibilityMove affinity tag to opposite terminus, use longer linker sequences
Co-purifying contaminantsNon-specific interactionsInclude imidazole (10-20 mM) in binding buffer, add additional purification steps

For particularly difficult cases, alternative approaches such as fusion to solubility-enhancing tags (MBP, SUMO, GST) or co-expression with binding partners may be necessary.

How can researchers distinguish between direct and indirect effects of CSN-4 deficiency?

Distinguishing direct from indirect effects requires a multi-layered experimental approach:

  • Temporal analysis: Identify early versus late responses following inducible CSN-4 depletion

  • Dose-dependency: Use partial knockdown or temperature-sensitive alleles to create a range of CSN-4 activity levels

  • Biochemical validation: Confirm direct interactions through in vitro reconstitution with purified components

  • Targeted mutations: Generate separation-of-function mutations that affect specific CSN-4 interactions

  • Differential analysis: Compare CSN-4 deficiency phenotypes with those of other CSN subunit deficiencies

A particularly effective approach combines an auxin-inducible degron system for rapid CSN-4 depletion with time-course omics analyses (transcriptomics, proteomics, metabolomics) to capture immediate versus secondary responses.

What data inconsistencies might arise when studying CSN-4 across different experimental systems, and how should they be reconciled?

Data inconsistencies may arise from:

  • Different model systems (in vitro reconstitution vs. cellular studies vs. organism-level analysis)

  • Variations in experimental conditions (buffer compositions, temperatures, protein concentrations)

  • Different detection methods with varying sensitivities

  • Post-translational modifications present in vivo but absent in recombinant systems

  • Species-specific differences when comparing N. crassa CSN-4 to homologs in other organisms

Reconciliation strategies include:

  • Standardization of experimental conditions across different systems when possible

  • Validation of key findings using multiple independent techniques

  • Direct comparison experiments performed under identical conditions

  • Careful consideration of physiological relevance when interpreting in vitro results

  • Collaboration with research groups using complementary approaches

When inconsistencies persist, they often reveal interesting biological phenomena rather than experimental artifacts, such as context-dependent functions or regulation of CSN-4 that may provide new research directions.

What emerging technologies hold promise for further elucidating CSN-4 function?

Several emerging technologies offer new opportunities for CSN-4 research:

  • Cryo-electron tomography to visualize CSN complexes in their native cellular environment

  • Single-molecule FRET to track real-time conformational changes during substrate binding

  • AlphaFold and other AI-based structural prediction tools to model CSN-4 interactions

  • CRISPR-based genomic screens to identify genetic interactions with CSN-4

  • Microfluidics-based approaches for high-throughput functional analysis of CSN-4 variants

Particularly promising is the integration of temporal and spatial information through combinations of live-cell imaging with proximity labeling techniques, allowing researchers to track CSN-4-containing complexes as they engage with different cellular machinery in response to environmental cues.

How might CSN-4 research contribute to understanding broader principles of multi-protein complex assembly?

CSN-4 research provides valuable insights into principles governing multi-protein complex assembly:

  • The role of PCI domains as a structural scaffold in diverse complexes (CSN, proteasome lid, eIF3)

  • The contribution of C-terminal helical bundles to complex stability and communication between subunits

  • The identification of stable subcomplexes as assembly intermediates

  • The integration of catalytic subunits as a final activation step

Comparative studies between CSN-4 and homologous subunits in related complexes (e.g., Rpn5 in the proteasome lid) can elucidate conserved assembly principles. Such research contributes to fundamental understanding of how multi-protein complexes achieve both stability and functional flexibility, with potential applications in designing synthetic protein complexes for biotechnology and medicine.

What are the implications of CSN-4 research for understanding cellular signaling networks in filamentous fungi?

CSN-4 research has broad implications for understanding fungal signaling networks:

  • Illuminating the intersection between protein degradation pathways and transcriptional control

  • Revealing mechanisms of environmental adaptation through regulated proteolysis

  • Understanding developmental transitions in filamentous fungi

  • Identifying potential targets for antifungal development

The integration of CSN-4/CSN function with nitrogen metabolism regulation exemplifies how protein stability control intersects with transcriptional networks to coordinate cellular responses to environmental conditions. This research may ultimately contribute to agricultural applications through improved understanding of plant-fungal interactions or medical applications by identifying novel antifungal targets in pathogenic fungi.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.